V
vikingwill
I have an view that non-medicinal consumer health products are more likely to be 'borderline' products (across e.g. cosmetics, articles, biocides) than health products intended to be used by professionals. In regions such as the EU, one can always go back to primary legislative definitions and guidance documents, but what about regions outside the GHTF domain? For example, in Russia, the registration process is reasonably well defined, if tortuous, but is there a functional definition of what a medical device is in Russia, or is this based on market precedent or local negotiation?